LifeStance and Dole Unveil FY26 Outlooks Amid Mixed Q4 Performance

The reporting period for the fourth quarter of 2025 has culminated in a significant strategic pivot for two mid-cap leaders, LifeStance Health Group (LFST) and Dole (DOLE). On February 25, 2026, both companies moved beyond immediate quarterly performance to introduce full-year 2026 (FY26) outlooks, signaling a shift toward long-term operational stability and multi-year planning. This forward-looking stance is particularly notable given the macroeconomic volatility that characterized the preceding fiscal year, suggesting that management teams in both the healthcare services and consumer staples sectors are gaining confidence in their visibility through the next 24 months.

LifeStance Health Group, a dominant player in the outpatient mental health market, continues to refine its business model from one of aggressive clinician acquisition to one of operational excellence. The introduction of an FY26 outlook suggests that the company has reached a critical mass in its clinician base and is now focusing on margin expansion through technology integration and improved payer contracting. For investors, the key metric remains clinician retention and the ability to convert high demand for mental health services into sustainable EBITDA growth. The transition to providing guidance for 2026 reflects a maturation of the platform, moving away from the 'growth-at-all-costs' narrative that followed its IPO and toward a disciplined, profitable scaling phase.

“

The reporting period for the fourth quarter of 2025 has culminated in a significant strategic pivot for two mid-cap leaders, LifeStance Health Group (LFST) and Dole (DOLE).

In contrast, Dole's Q4 results were characterized as 'mixed,' a term that often masks a complex interplay between robust top-line revenue and pressured bottom-line margins. As a global leader in fresh produce, Dole remains highly sensitive to logistics costs, climate-driven crop yields, and currency fluctuations. The 'mixed' nature of the results likely stems from the persistent inflationary pressure on shipping and packaging, which has offset gains in the fresh fruit segment. By introducing an FY26 outlook alongside these results, Dole is attempting to anchor investor expectations around its supply chain resilience and its ability to pass through costs to consumers in a staple-heavy market. The 2026 guidance will be a critical benchmark for how the company intends to navigate the ongoing transition toward more sustainable and technologically-driven agricultural practices.